13.04.2025, 1147 Zeichen

Semperit: The tariffs imposed by the US on imports of varying amounts, as well as a continued slowdown in order intake and the resulting capacity adjustments will have a significant impact on the current business performance of Semperit AG Holding, a producer of elastomer products and applications. Against this background and assuming that the recently announced tariffs will remain unchanged for Semperit’s main production sites, the Executive Board expects an operating EBITDA in the range of EUR 65 million to EUR 85 million (originally: EUR 70 million to EUR 90 million) for the 2025 financial year. In view of the current high level of uncertainty regarding further or modified protectionist measures and the start of a broader economic recovery, the medium-term target, according to which operating EBITDA should reach around EUR 120 million in 2026, has been suspended for the time being. In the 2024 financial year, the US market accounted for around EUR 76 million of revenue (total revenue: EUR 676.6 million).
Semperit: weekly performance: 3.33%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (09/04/2025)

Christian Drastil: Wiener Börse Plausch

kapitalmarkt-stimme.at daily voice 110/365: Zahlen/Fakten nach Woche 16, damit man bzgl. Wr. Börse mitreden und sie einreihen kann

Bildnachweis

Aktien auf dem Radar:Frequentis, Porr, Österreichische Post, Addiko Bank, Pierer Mobility, RHI Magnesita, Verbund, EVN, CPI Europe AG, Bawag, VIG, OMV, Telekom Austria, Uniqa, Amag, Wolford, Oberbank AG Stamm, Marinomed Biotech, CA Immo, Erste Group, FACC, Kapsch TrafficCom, Polytec Group, RBI, Rosenbauer, SBO, Semperit, Strabag, Wienerberger, Flughafen Wien, Fresenius Medical Care.

---